ICONOVO
ICONOVO is a Swedish privately funded device company with a business model to supply the market with unique, safe and cost efficient inhalation devices. ICONOVO has long and unique experience and capability in the development of inhalation devices. ICONOVO’s products combine technical complexity with user friendly and attractive design. ICONOVO’s ambition is to become a leading supplier on a global market and to within 5 years achieve a multimillion turnover and a positive result.
ICONOVO
Social Links:
Industry:
Industrial Design Innovation Management Medical Device Pharmaceutical
Founded:
2013-01-01
Address:
Lund, Skane Lan, Sweden
Country:
Sweden
Website Url:
http://www.iconovo.se
Total Employee:
1+
Status:
Active
Contact:
+46 7654 22220
Total Funding:
12.19 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Global Site Tag Sitelinks Search Box Organization Schema
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Altamira Therapeutics
Altamira Therapeutics develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Spencer Health Solutions
Spencer Health Solutions is a developer of an in-home medication dispenser.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Iconovo
Key Employee Changes
| Date | New article |
|---|---|
| 2020-07-09 | BioStock: Iconovo adds business development experience with new CEO |
Official Site Inspections
http://www.iconovo.se
- Host name: se2.intendit.se
- IP address: 152.115.36.106
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
More informations about "Iconovo"
Iconovo implements organizational changes to increase focus on …
Apr 24, 2025 Iconovo AB (publ), a leading company in the development of inhalable drugs based on proprietary inhalers and dry powder formulations, today announces that the …See details»
Iconovo announces it will downsize and focus on …
Apr 29, 2025 Iconovo CEO Johan Wäborg commented, “After successfully completing the development of all our inhaler platforms, including ICOpre, it is a natural step to continue …See details»
Iconovo AB - Devex
Learn more about Iconovo AB's jobs, projects, latest news, contact information and geographical presence. ... Type of organization. Goods Supplier . Sweden . 1 office. https://www.iconovo.se ...See details»
Iconovo implements organizational changes to increase focus on …
Apr 24, 2025 Iconovo AB (publ), a leading company in the development of inhalable drugs based on proprietary inhalers and dry powder formulations, today announces that the …See details»
Iconovo Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Iconovo has 5 employees at their 1 location and kr7.08 m in annual revenue in FY 2023. See insights on Iconovo including office locations, competitors, revenue, financials, …See details»
Iconovo - Crunchbase Company Profile & Funding
ICONOVO is a Swedish privately funded device company with a business model to supply the market with unique, safe and cost efficient inhalation devices. ICONOVO has long and unique experience and capability in the development …See details»
MFN.se > Iconovo > Iconovo genomför organisationsförändringar …
Apr 24, 2025 Iconovo AB (publ), en ledande aktör inom utveckling av inhalerbara läkemedel baserade på egenutvecklade inhalatorer och torrpulverformuleringar, meddelar idag att …See details»
Iconovo – Breathtaking Innovation
Iconovo develops new inhaled medicinal products in collaboration with international pharmaceutical companies. The company offers several types of patented dry powder inhaler devices, and …See details»
Iconovo AB (STO:ICO) Company Profile & Description - Stock …
Iconovo AB (publ) develops and licenses inhalation medications in Sweden. The company offers ICOres, a flexible multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; …See details»
Iconovo AB - A Company At Ideon - Ideon Science Park
Iconovo AB. Address. Ideongatan 3A-B, 223 70 Lund. Building. Delta 6. Company website. www.iconovo.se. Phone. 046-275 67 77. E-mail. [email protected]. About Ideon. …See details»
Investors - Iconovo
Iconovo attended the Carnegie Healthcare Webinar. Juni 2024, engelska. ... Iconovo AB Ideongatan 3A-B SE-223 70 LUND Sweden. CONTACT. Phone: +46 46 275 67 77. VP …See details»
Iconovo AB: Iconovo implements organizational changes to …
Apr 24, 2025 Johan Wäborg, CEO +46 707 78 51 71 [email protected]. About Iconovo. Iconovo (Nasdaq First North Growth Market: ICO) develops new inhaled medicinal products in …See details»
MFN.se > Iconovo > Iconovo implements organizational changes …
Iconovo AB (publ), a leading company in the development of inhalable drugs based on proprietary inhalers and dry powder formulations, today announces that the company is planning an …See details»
Iconovo AB - Informationsdokument inför företrädesemission
Iconovo AB (”Iconovo” eller ”Bolaget”) är ett publikt aktiebolag registrerat i Sverige. Bolagets organisationsnummer är 556938-0156 och Bolagets LEI-kod är 549300CH7SEE52V2WD15. …See details»
KVARTALSRAPPORT Q1 2025 | Iconovo
Apr 24, 2025 Tel +46 46 275 6777, [email protected], www.iconovo.se Organisationsnummer Iconovo AB, 556938-0156. Certified Adviser Carnegie Investment Bank AB (publ), …See details»
Iconovo genomför organisationsförändringar för ökat fokus på ...
Apr 24, 2025 Iconovo AB (publ), en ledande aktör inom utveckling av inhalerbara läkemedel baserade på egenutvecklade inhalatorer och torrpulverformuleringar, meddelar idag att …See details»
MFN.se > Iconovo > Iconovo implements organizational changes …
Iconovo AB (publ), a leading company in the development of inhalable drugs based on proprietary inhalers and dry powder formulations, today announces that the company is planning an …See details»
About us - Iconovo
Iconovo develops ready-to-use inhalation products – inhaler devices and dry powder formulations for generic drug companies and pharmaceutical companies. ... Iconovo AB Ideongatan 3A-B …See details»
Iconovo publishes information document regarding rights issue of …
3 days ago Iconovo AB ("Iconovo" or the "Company") publishes an information document (the "Information Document") relating to the rights issue of shares of approximately 36.6 MSEK …See details»
Iconovo offentliggör informationsdokument avseende …
3 days ago Iconovo AB ("Iconovo" eller ”Bolaget”) offentliggör ett informationsdokument (”Informationsdokumentet”) med anledning av den företrädesemission av aktier om cirka 36,6 …See details»